{
    "2020-07-04": [
        [
            {
                "time": "",
                "original_text": "医药投向标|新版化药、生物制品注册分类出台；君实生物确定科创板发行价55.50元/股；长风药业半年内再获3.6亿元F轮融资",
                "features": {
                    "keywords": [
                        "化药",
                        "生物制品",
                        "注册分类",
                        "君实生物",
                        "科创板",
                        "长风药业",
                        "F轮融资"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "壹心科技携手美年大健康 筑起健康+保险双保障",
                "features": {
                    "keywords": [
                        "壹心科技",
                        "美年大健康",
                        "健康+保险"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "健康",
                        "保险"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}